West Pharmaceutical Services, Inc.
WST
$214.55
$3.961.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.12% | -5.04% | -15.69% | -28.24% | -17.64% |
| Total Depreciation and Amortization | 12.36% | 13.37% | 12.61% | 14.08% | 12.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -126.32% | -110.69% | -51.81% | -86.79% | -85.71% |
| Change in Net Operating Assets | 100.29% | -12.64% | -100.40% | 155.73% | 26.07% |
| Cash from Operations | 9.48% | -20.49% | -21.73% | -2.48% | -14.41% |
| Capital Expenditure | 21.30% | 3.50% | 15.14% | -32.89% | -10.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 200.00% | -900.00% | 85.07% | -- |
| Cash from Investing | 21.30% | 3.68% | 14.21% | -23.26% | -10.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 71.43% | 85.71% | -22,100.00% | -11,580.00% | -16.67% |
| Issuance of Common Stock | -73.81% | 0.00% | -70.59% | -44.26% | 9.80% |
| Repurchase of Common Stock | 50.07% | 69.17% | -86.48% | -7.34% | -280.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.40% | -3.38% | -3.57% | -3.55% | -4.26% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 45.76% | 63.64% | -188.79% | -23.47% | -281.69% |
| Foreign Exchange rate Adjustments | 197.70% | -256.55% | 213.27% | -266.67% | -224.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.11% | 85.91% | -56.30% | -72.89% | -3,051.25% |